First Trust NYSE Arca Biotechnology Index Fund (FBT)

Assets	$3.14B
Expense Ratio	0.55%
PE Ratio	31.41
Forward PE	21.71
Shares Out	11.20M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	n/a
Open	n/a
Previous Close	280.30
Day's Range	n/a
52-Week Low	186.20
52-Week High	283.21
Beta	0.67
Holdings	33
Inception Date	Jun 19, 2006

About FBT

Fund Home Page

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: FBT
• ETF Provider: First Trust
• Index Tracked: NYSE Arca Biotechnology Index

Top 10 Holdings

36.76% of assets

Name	Symbol	Weight
Genmab A/S	GMAB	4.82%
Halozyme Therapeutics, Inc.	HALO	3.75%
Veracyte, Inc.	VCYT	3.65%
ADMA Biologics, Inc.	ADMA	3.58%
Alkermes plc	ALKS	3.53%
Amgen Inc.	AMGN	3.51%
Biogen Inc.	BIIB	3.50%
Exelixis, Inc.	EXEL	3.50%
Regeneron Pharmaceuticals, Inc.	REGN	3.47%
NeoGenomics, Inc.	NEO	3.47%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 13, 2024	$1.1726	Dec 31, 2024
Sep 23, 2015	$0.0197	Sep 30, 2015
Jun 24, 2015	$0.0649	Jun 30, 2015
Mar 25, 2015	$0.0476	Mar 31, 2015
Dec 23, 2014	$0.0524	Dec 31, 2014
Jun 23, 2008	$0.2697	Jun 30, 2008

Performance

FBT had a total return of 47.78% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.93%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 31, 2026

Data Sources Report a data error